These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10803512)

  • 1. BIOMED-1 concerted action report: flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL).
    Porwit-MacDonald A; Björklund E; Lucio P; van Lochem EG; Mazur J; Parreira A; van den Beemd MW; van Wering ER; Baars E; Gaipa G; Biondi A; Ciudad J; van Dongen JJ; San Miguel JF; Orfao A
    Leukemia; 2000 May; 14(5):816-25. PubMed ID: 10803512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia.
    Björklund E; Mazur J; Söderhäll S; Porwit-MacDonald A
    Leukemia; 2003 Jan; 17(1):138-48. PubMed ID: 12529671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL.
    Lúcio P; Parreira A; van den Beemd MW; van Lochem EG; van Wering ER; Baars E; Porwit-MacDonald A; Bjorklund E; Gaipa G; Biondi A; Orfao A; Janossy G; van Dongen JJ; San Miguel JF
    Leukemia; 1999 Mar; 13(3):419-27. PubMed ID: 10086733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation.
    Lucio P; Gaipa G; van Lochem EG; van Wering ER; Porwit-MacDonald A; Faria T; Bjorklund E; Biondi A; van den Beemd MW; Baars E; Vidriales B; Parreira A; van Dongen JJ; San Miguel JF; Orfao A;
    Leukemia; 2001 Aug; 15(8):1185-92. PubMed ID: 11480560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometry.
    Ginaldi L; Farahat N; Matutes E; De Martinis M; Morilla R; Catovsky D
    J Clin Pathol; 1996 Jul; 49(7):539-44. PubMed ID: 8813949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
    Dworzak MN; Fröschl G; Printz D; Zen LD; Gaipa G; Ratei R; Basso G; Biondi A; Ludwig WD; Gadner H
    Leukemia; 2004 Apr; 18(4):703-8. PubMed ID: 14961034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J; Orfao A; Vidriales B; Macedo A; Martínez A; González M; López-Berges MC; Valverde B; San Miguel JF
    Haematologica; 1998 Dec; 83(12):1069-75. PubMed ID: 9949623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of minimal residual T cell acute lymphoblastic leukemia by flow cytometry.
    Gore SD; Kastan MB; Goodman SN; Civin CI
    J Immunol Methods; 1990 Sep; 132(2):275-86. PubMed ID: 1698878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of CD45 RA/RO isoformic antigens in T-lineage neoplasms.
    Kawano S; Tatsumi E; Yoneda N; Tani A; Nakamura F
    Am J Hematol; 1995 May; 49(1):6-14. PubMed ID: 7741140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
    Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
    Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
    Li S; Juco J; Mann KP; Holden JT
    Am J Clin Pathol; 2004 Feb; 121(2):268-74. PubMed ID: 14983942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses.
    Harmon CB; Witzig TE; Katzmann JA; Pittelkow MR
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):404-10. PubMed ID: 8784277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophenotype of acute lymphoblastic leukemia cells: the experience of the Italian Cooperative Group (Gimema).
    De Rossi G; Grossi C; Foà R; Tabilio A; Vègna L; Lo Coco F; Annino L; Camera A; Cascavilla N; Ciolli S
    Leuk Lymphoma; 1993 Feb; 9(3):221-8. PubMed ID: 8471981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunophenotype of pre-TALL/LBL revisited.
    Lewis RE; Cruse JM; Sanders CM; Webb RN; Tillman BF; Beason KL; Lam J; Koehler J
    Exp Mol Pathol; 2006 Oct; 81(2):162-5. PubMed ID: 16908018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD7 is expressed on a subset of normal CD34-positive myeloid precursors.
    Kriegsmann K; Löffler H; Eckstein V; Schulz R; Kräker S; Braun U; Luft T; Hegenbart U; Schönland S; Dreger P; Krämer A; Ho AD; Müller-Tidow C; Hundemer M
    Eur J Haematol; 2018 Sep; 101(3):318-325. PubMed ID: 29797671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.
    Inokuchi K; Iwakiri R; Futaki M; Hanawa H; Tanosaki S; Nomura T; Dan K
    Leuk Lymphoma; 1998 May; 29(5-6):553-61. PubMed ID: 9643569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low level CD20 expression on T cell malignancies.
    Warzynski MJ; Graham DM; Axtell RA; Zakem MH; Rotman RK
    Cytometry; 1994 Jun; 18(2):88-92. PubMed ID: 7523045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.